Clinical trial

A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase…

NCT01395641 · National Taiwan University Hospital, Other · Completed

Key facts

NCT number NCT01395641
Title A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC
Official title A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC
Acronym AADC
Lead sponsor National Taiwan University Hospital, Other
Collaborators PTC Therapeutics Industry
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
Intervention type Drug
Interventions gene therapy
Enrollment 10
Start date Oct 22, 2014
Primary completion Dec 18, 2020
Completion Mar 7, 2022
First posted Jul 15, 2011
Last update posted Feb 10, 2023
Countries Taiwan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies